Biocompounding
3 Top Biotech News Of The Week (1 October 22)
1) Eisai and Biogen Report Positive Phase III Data for Anti-Amyloid Alzheimer's Drug
Eisai and Biogen announced that the duo’s Alzheimer's drug, Lecanemab, slowed the rate of cognitive decline for early Alzheimer’s participants in the phase 3 clinical trial by 27% compared to a
An Overview of RNA Technologies
RNA technologies made headlines in 2021 when the first mRNA-based COVID-19 vaccine was approved in December 2020.
However, RNA therapy is not a new technology. RNA modalities have been under development for several decades and by Jan 2020, the U.S Food and Drug Administration (FDA) had approved a total
3 Top Biotech News Of The Week (17 September 22) - Bioeconomy executive order, BioMarin, Danaher, Intellia
1. The US Govt just released the Executive Order for advancing biotechnology and biomanufacturing for a sustainable, safe, and secure bioeconomy.
There are 11 areas they will be looking to fund and develop within this niche. Here is a quick summary:
1. Coordinate investment in key R&D areas
3 Top Biotech News Of The Week (10 September 22)
1. Iveric plans FDA submission of data for geographic atrophy eye-drug following study success
Iveric Bio announced positive phase 3 topline data from Zimura for geographical atrophy (GA). Zimura is a novel investigational complement C5 inhibitor.
Overactivity of the complement system and the C5 protein are suspected to play a
3 Top Biotech News Of The Week (3 September 22)
1. FDA clears updated COVID-19 boosters from Pfizer, Moderna
A long-awaited moment!
On Wednesday, FDA approved a new version of Pfizer’s vaccine for adults and children over 12 years old and Moderna’s modified shot for adults who are 18 or older.
Both vaccines are bivalent, meaning that they
